Is NYSE:BMA suited for growth investing?

In this article we will dive into BANCO MACRO SA-ADR (NYSE:BMA) as a possible candidate for growth investing. Investors should always do their own research, but we noticed BANCO MACRO SA-ADR showing up in our CANSLIM growth screen, which makes it worth to investigate a bit more.

Why NYSE:BMA may be interesting for canslim investors.

• The recent financial report of BANCO MACRO SA-ADR demonstrates a 3.0K% increase in quarterly earnings compared to the previous quarter. This growth indicates positive momentum in the company's financials and suggests a promising upward trend
• The quarter-to-quarter (Q2Q) revenue growth of 668.0% of BANCO MACRO SA-ADR has been strong, reflecting the company's ability to generate consistent sales growth. This growth suggests the company's ability to meet customer needs and drive revenue growth.
• Over the past 3 years, BANCO MACRO SA-ADR has demonstrated 170.0% growth in EPS, signifying its positive financial trajectory and potential for future profitability.
• BANCO MACRO SA-ADR has achieved an impressive Return on Equity (ROE) of 25.68%, showcasing its ability to generate favorable returns for shareholders.
• BANCO MACRO SA-ADR has exhibited strong Relative Strength(RS) in recent periods, with a current 97.95 rating. This indicates the stock's ability to outperform the broader market and reflects its competitive position. BANCO MACRO SA-ADR shows promising potential for continued price momentum.
• With a current Debt-to-Equity ratio at 0.14, BANCO MACRO SA-ADR showcases its disciplined capital structure. The company's prudent management of debt obligations contributes to its financial stability and long-term sustainability.
• With 7.32% of the total shares held by institutional investors, BANCO MACRO SA-ADR showcases a healthy distribution of ownership. This suggests a mix of institutional and retail investors, fostering a dynamic market for the stock.

Zooming in on the technicals.

Every day ChartMill assigns a Technical Rating to every stock. The score ranges from 0 to 10 and is determined by evaluating multiple technical indicators and properties.

We assign a technical rating of 7 out of 10 to BMA. In the last year, BMA was one of the better performers in the market. There are positive signs in the very recent evolution, but the medium term picture is slightly mixed.

• The short term trend is positive, while the long term trend is neutral. So this is evolving in the right direction.
• When comparing the yearly performance of all stocks, we notice that BMA is one of the better performing stocks in the market, outperforming 97% of all stocks.
• BMA is one of the better performing stocks in the Banks industry, it outperforms 99% of 403 stocks in the same industry.
• BMA is currently trading in the upper part of its 52 week range. The S&P500 Index is also trading in the upper part of its 52 week range, so BMA is performing more or less in line with the market.
• In the last month BMA has a been trading in the 42.23 - 60.50 range, which is quite wide. It is currently trading near the high of this range.
• Prices have been rising strongly lately, it may be a good idea to wait for a consolidation or pullback before considering an entry.

Our latest full technical report of BMA contains the most current technical analsysis.

Fundamental analysis of NYSE:BMA

ChartMill assigns a Fundamental Rating to every stock. This score ranges from 0 to 10 and is updated daily. The score is determined by evaluating multiple fundamental indicators and properties.

Overall BMA gets a fundamental rating of 3 out of 10. We evaluated BMA against 403 industry peers in the Banks industry. BMA has a bad profitability rating. Also its financial health evaluation is rather negative. BMA is valued quite expensively, but it does show have an excellent growth rating.

Our latest full fundamental report of BMA contains the most current fundamental analsysis.

More ideas for growth investing can be found on ChartMill in our CANSLIM screen.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.